CAP-CMV's Series A Round

CAP-CMV raised a round of funding on March 24, 2014.

CAP-CMV is a spin-out of CEVEC Pharmaceuticals and focuses exclusively on the development of a novel vaccine protecting against human Cytomegalovirus (HCMV) infection. The approach of CAP-CMV is the u…

Articles about CAP-CMV's Series A Round: